Standout Papers

Frequency of prolonged remission duration after high-dose cytarabine intensification in acute ... 1998 2026 2007 2016 505
  1. Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype. (1998)
    Clara D. Bloomfield, David Lawrence et al. PubMed

Immediate Impact

38 by Nobel laureates 17 from Science/Nature 65 standout
Sub-graph 1 of 19

Citing Papers

Acute myeloid leukaemia
2018 Standout
Acute myeloid leukaemia in adults
2013 Standout
95 intermediate papers

Works of Frederick R. Davey being referenced

Repetitive Cycles of High-Dose Cytarabine Benefit Patients With Acute Myeloid Leukemia and inv(16)(p13q22) or t(16;16)(p13;q22): Results from CALGB 8461
2004
Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype.
1998 Standout
and 11 more

Author Peers

Author Last Decade Papers Cites
Frederick R. Davey 2238 879 783 1192 978 107 3.7k
Diane C. Arthur 1960 1081 599 931 1002 77 4.0k
Guido Kobbe 3699 1313 942 1009 1101 200 5.1k
Francesco Lanza 2070 802 889 580 785 158 3.7k
Kenneth F. Bradstock 2236 667 1332 859 1351 154 4.6k
G Jánossy 1223 735 1566 851 776 59 3.5k
Giovanna Meloni 3682 1044 500 1934 1289 160 5.5k
Marco Gobbi 1874 882 959 450 1014 169 3.9k
John Kersey 1870 705 813 770 548 66 3.4k
Yang O. Huh 2407 1553 1352 1171 652 103 4.6k
Karl S. Theil 2219 888 305 778 1176 73 3.5k

All Works

Loading papers...

Rankless by CCL
2026